Pulmonary Embolism Flashcards

(87 cards)

1
Q

T/F: DVT can be located only in the lower extremities

A

F: It can be in either upper or lower extremities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

It is a condition characterized by the presence of a clot in the deep venous sytem

A

Deep Vein Thrombosis (DVT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the pathway of the clot causing pulmonary embolism?

A

Vena cava -> right atrium -> right ventricle -> pulmonary artery -> clot lodges at PA -> pulmonary embolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

This medical condition occurring after DVT/PE is characterized by symptoms of breathlessness, especially with exertion

a. Post-PE Syndrome
b. Chronic Thromboembolic pulmonary Hypertension (CTEPH)
c. Post-thrombotic syndrome

A

b. Chronic Thromboembolic pulmonary Hypertension (CTEPH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

This medical condition occurring after DVT/PE could present with right ventricular dysfunction after PE diagnosis

a. Post-PE Syndrome
b. Chronic Thromboembolic pulmonary Hypertension (CTEPH)
c. Post-thrombotic syndrome

A

a. Post-PE Syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

This medical condition occurring after DVT/PE may subsequently cause CTEPH

a. Post-PE Syndrome
b. Chronic Thromboembolic pulmonary Hypertension (CTEPH)
c. Post-thrombotic syndrome

A

a. Post-PE Syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

This medical condition occurring after DVT/PE damages the venous valves of the leg, causing ankle/calf swelling and leg aching after prolonged standing

a. Post-PE Syndrome
b. Chronic Thromboembolic pulmonary Hypertension (CTEPH)
c. Post-thrombotic syndrome

A

c. Post-thrombotic syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

T/F: The most severe form of post-PE syndrome could cause deep skin ulcerations

A

F: it’s the most severe form of post-thrombotic syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Trigger of acute PE and DVT

A

Inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

T/F: Type 2 DM can trigger PE or DVT

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Most common autosomal dominant genetic mutations

A

Factor V Leiden and Prothrombin gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How do Factor V Leiden and prothrombin gene influence DVT/PE?

A

Factor V Leiden causes resistance to activated anticoagulant protein C

Prothrombin gene increases plasma prothrombin concentration -> increased coagulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

T/F: Factor V Leiden and Prothrombin gene mutations do NOT appear to increase the risk of RECURRENT VTE

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

T/F Antiphospholipid antibody syndrome is a genetic thrombophilic disorder that predisposes to venous and arterial thrombosis

A

F: it is ACQUIRED

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the three contributing factors in the formation of thrombosis (Virchow’s Triad)?

A

Venous stasis, hypercoagulability, endothelial injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

T/F Low oxygen tension promote venous thrombi formation

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How does the virchow’s triad form venous thrombi?

A

The vascular injury and venous stasis will stimulate activated platelets (increased by hypercoagulability)&raquo_space; activated platelets will release microparticles, which contain proinflammatory mediators that bind to neutrophils&raquo_space; bound neutrophils will release materials and form “neutrophil extracellular traps (NET)”&raquo_space; NET contains histones that would further stimulate platelet aggregation and promote platelet-dependent thrombin generation&raquo_space; formation of venous thrombi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

T/F: Patients suffering from VTE are more than 2x likely to have future MI or stroke

A

T
Since VTE, stroke, and acute coronary syndrome share similar risk factors and pathophysiology involving inflammation, endothelial injury, hypercoagulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

T/F: In PE, pressure overload in the left ventricle increases its wall tension, leading to left ventricle ischemia and dysfunction. It also dilates, compressing the adjacent normal right ventricle, resulting to its decreased CO and systemic arterial pressure&raquo_space; circulatory collapse and death

A

F
The RV experiences Pressure overload
the LV gets compressed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Types of pulmonary embolism

A

Low-risk
Submassive (Intermediate-risk)
Massive (high-risk)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Hallmarks of massive PE

A

Dyspnea, hypotension, syncope, cyanosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

This type of PE has RV dysfunction despite having normal systemic arterial pressure

A

Submassive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Types of DVT

A

Lower Extremity
Upper Extremity
Superficial Venous Thrombosis (primarily not a DVT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Most common symptom of pulmonary embolism

A

Unexplained breathlessness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Most common symptom of deep vein thrombosis
Cramp or "Charley horse" in the lower calf that persists and intensifies over several days
26
This help estimate clinical likelihood of DVT and PE
Wells point Scoring
27
T/F: In High DVT/PE, Blood test such as D-dimer test should be skipped
T Should undergo diagnostic imaging tests instead
28
T/F In low and low-moderate PE, there are no obligatory imaging tests
T
29
T/F Age-adjusted dimer is NOT applicable to patients suspected of acute DVT
T
30
Age adjusted D Dimer is applicable to more than ___ yo and with ______ clinical probability of PE
>50 yo; low or moderate
31
Standard upper limit in ng/mL of age-adjusted D dimer
500 ng/mL formula: age x 10
32
Most cited ECG abnormality aside from sinus tachycardia
S1Q3T3 sign (specific but NOT sensitive) s wave in lead I, Q wave, and an inverted T wave
33
Most common ECG abnormality
T wave inversion in leads V1 to V4 due to RV myocardial strain and ischemia
34
35
Principal diagnostic test for suspected DVT
Venous Ultrasonography
36
Primary diagnostic criterion for DVT in venous ultrasound
Loss of vein compressibility
37
3 Well-established xray abnormalities in PE
Westermark's sign, Hampton's hump, Palla's Sign
38
This Xray abnormality in PE shows reduction in the pulmonary volume
Westermark's sign
39
This xray abnormality in PE shows wedge-shaped density usually at the pleural base
Hampton's Hump
40
This is the sign of sausage appearance in chest xray of PE due to enlarged right descending pulmonary artery
Palla's Sign
41
What is the enlarged structure seen in Palla's Sign?
(Right) descending pulmonary artery
42
This imaging modality is the principal imaging test for PE diagnosis
Chest CT
43
T RV Enlargement indicates an increase likelihood of death in 7 days
F: 30 days
44
Second-line diagnostic test for PE
Lung Scan (Ventilation-Perfusion Scan) for patients who cannot tolerate intravenous contrast
45
90% certain of PE if the ff are seen in lung scan:
Two or more segmental perfusion defects with normal ventilation (VQ Mismatch)
46
T/F Contrast-enhanced MRI can be used to detect large proximal, and smaller segmental/subsegmental PE
F Unreliable for smaller segmental and subsegmental PE
47
Abnormal chest CT but without PE could have the following alternative diagnoses:
Pneumonia, emphysema, pulmonary fibrosis, pulmonary mass, aortic pathology
48
Possible other differentials in lung scan with abnormal ventilation
Asthma, COPD
49
T/F Echocardiography can be used in diagnosing PE
F : it would have normal results
50
What diseases can mimic PE in Echo?
Acute MI, pericardial tamponade, aortic dissection
51
Best known indirect sign of PE on transthoracic echocardiography
McConnel's Sign - hypokinesia of RV free wall with normal or hyperkinetic RV Apex
52
If there's an unsatisfactory chest CT results or plans for catheter-directed thrombolysis, this diagnostic modality is indicated
Pulmonary Angiography
53
T/F: Venous ultrasound is also used when lung scan for PE diagnosis is unsatisfactory
T
54
Chest CT: What contrast is the primary diagnostic modality for PE?
Iodine Contrast
55
Primary therapy for DVT
Clot dissolution that uses iodine contrast
56
Secondary prevention for DVT
Anticoagulation or placement of an inferior vena cava filter
57
Which anticoagulant is useful when hour to hour control of intensity of anticoagulation is desired? a. UFH b. LMWH c. Fondaparinux d. Warfarin
a. UFH
58
T/F Lab monitoring is needed when taking UFH
T Lab monitoring is needed to target apTT of 60-80s
59
T/F UFH has pleiotropic effects that may decrease systemic and local inflammation
T
60
T/F No lab monitoring or dose adjustment is needed in using LMWH, except if obese or with CKD
T
61
dosing of this weight-based anticoagulant must be adjusted downwards for patients with renal dysfunction a. UFH b. LMWH c. Fondaparinux d. Warfarin
Fondaparinux
62
Daily therapy for at least _______ days is required for the full effect of warfarin
5 days
63
T/F Fondaparinux has suspected or proven heparin-induced thrombocytopenia
F DTI (Argatroban and Bivalirudin) has HIT
64
This LMWH has a dosage of 1 mg/kg twice daily with normal renal function a. Enoxaparin b. Dalteparin c. Tinzaparin
A. enoxaparin
65
This LMWH has a dosage of 200U/kg daily or 100U/kg twice daily with normal renal function a. Enoxaparin b. Dalteparin c. Tinzaparin
b. Dalteparin
66
This LMWH has a dosage of 175U U/kg once daily with normal renal function a. Enoxaparin b. Dalteparin c. Tinzaparin
c. Tinzaparin
67
This anticoagulant is taken 15mg twice daily for 3 weeks, followed by 20 mg once daily with dinner meal thereafter a. Rivaroxaban b. Apixaban c. Dabigatran d. Edoxaban
a. Rivaroxaban
68
This anticoagulant is taken 10mg twice daily for 1 week, followed by 5mg twice daily a. Rivaroxaban b. Apixaban c. Dabigatran d. Edoxaban
b. Apixaban
69
This is taken at 150mg twice daily after having 5 days of unfractionated heparin/LMWH/fondaparinux. a. Rivaroxaban b. Apixaban c. Dabigatran d. Edoxaban
c. Dabigatran
70
This is taken at 60mg once daily after having 5 days of unfractionated heparin/LMWH/fondaparinux. a. Rivaroxaban b. Apixaban c. Dabigatran d. Edoxaban
d. Edoxaban
71
Usual start dose of warfarin
5 mg
72
Antidote for heparin/LMWH hemorrhage
Protamine Sulfate
73
Antidote for dabigatran
Idarucizumab
74
Antidote for antiXa anticoagulants complications (Rivaroxaban/Apixaban)
Andexanet
75
Antidote for major bleeding from warfarin
Prothrombin complex concentrate
76
Antidote for less serious bleeding from warfarin
Fresh frozen plasma or IV Vitamin K
77
Minor bleeding from wrfarin or excessively high INR in the absence of bleeding
Oral vitamin K In order of severity (antidotes) Oral vitamin K >> Fresh frozen plasma or IV Vitamin K >> Prothrombin complex concentrate
78
T/F LMWH is prescribed as monotherapy for px with cancer and VTE
T
79
2 principal indications for IVC filter insertion
For active bleeding that precludes anticoagulation For recurrent venous thrombosis despite intensive anticoagulation
80
First line vasopressor agent for treatment of PE-related shock
Norepinephrine
81
First line inotropic agent
Dobutamine
82
Fibrinolysis: administration of ____ mg rtPA as a continuous peripheral intravenous infusion over ___ hrs
100 mg; 2 hrs
83
This combines physical fragmentation of thrombus and catheter-directed low-dose thrombolysis
Pharmacomechanical catheter-directed therapy
84
Aside from fibrinolysis, ________ is an option to avert risk of major hemorrhage
Pulmonary embolectomy
85
Indicated for patients with CTEPH (Chronic Thromboembolic Pulmonary Hypertension)
Pulmonary Thromboendarterectomy
86
In-hospital prophylaxis offered for hospitalized patients to avoid VTE
low dose UFH or LMWH
87
This is approved as continuing prophylaxis after discharge